We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

13 hedge funds and large institutions have $1.01M invested in NeuroMetrix, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

18% more funds holding

Funds holding: 1113 (+2)

17% more capital invested

Capital invested by funds: $867K → $1.01M (+$145K)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
13
Holders Change
+2
Holders Change %
+18.18%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$496K +$36.7K +362 +8%
Renaissance Technologies
2
Renaissance Technologies
New York
$284K +$96.3K +949 +55%
Millennium Management
3
Millennium Management
New York
$59K +$56.2K +554 New
TDC
4
Thompson Davis & Co
Virginia
$52K -$44.5K -438 -47%
BlackRock
5
BlackRock
New York
$20K
Goldman Sachs
6
Goldman Sachs
New York
$20K +$18.8K +185 New
TSS
7
Two Sigma Securities
New York
$19K -$1.52K -15 -8%
NSIM
8
North Star Investment Management
Illinois
$19K
Vanguard Group
9
Vanguard Group
Pennsylvania
$16K +$15.1K +149 New
OFS
10
Orrstown Financial Services
Pennsylvania
$13K
RC
11
Randolph Company
Ohio
$13K +$12.7K +125 New
UBS Group
12
UBS Group
Switzerland
$1K -$1.01K -10 -45%
VF
13
Virtu Financial
New York
-$46K -437 Closed
Citadel Advisors
14
Citadel Advisors
Florida
-$20K -189 Closed

NURO Hedge Fund Activity: Q3 2018 in Review

13 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2018, worth a combined $1.01M — up 17% from $867K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NURO positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $96.3K. The largest seller was Virtu Financial, exiting entirely with an estimated $46K sold.

  • 13 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2018, up from 11 in Q2 2018.
  • Funds reported $1.01M of NeuroMetrix, Inc. Common Stock stock for Q3 2018, up 17% quarter-over-quarter.
  • 4 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2018 and 2 closed out, a net change of +2 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2018 was Renaissance Technologies, an estimated $96.3K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q3 2018 was Virtu Financial, an estimated $46K sold.

Based on aggregated 13F filings for Q3 2018.